Cellosaurus LAPC4-PDR1 (CVCL_C0RQ)
| Cell line name | LAPC4-PDR1 |
|---|---|
| Synonyms | LAPC4 PDR1; L4-PDR1 |
| Accession | CVCL_C0RQ |
| Resource Identification Initiative | To cite this cell line use: LAPC4-PDR1 (RRID:CVCL_C0RQ) |
| Comments | Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line). Selected for resistance to: ChEBI; CHEBI_85993; Palbociclib (Ibrance). Omics: Proteomics; PTM; Phosphorylation; Quantitative. Omics: Transcriptomics; RNAseq. Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. |
| Sequence variations |
|
| Disease | Prostate carcinoma (NCIt: C4863) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_4744 (LAPC-4) |
| Sex of cell | Male |
| Age at sampling | Age unspecified |
| Category | Cancer cell line |
| Publications | PubMed=29739788; DOI=10.1158/1078-0432.CCR-18-0410; PMCID=PMC6125187 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_C0RQ |
| Encyclopedic resources | Wikidata; Q112929984 |
| Gene expression databases | GEO; GSM2649993
GEO; GSM2649994 GEO; GSM2649995 GEO; GSM2649996 GEO; GSM2649997 GEO; GSM2649998 |
| Proteomic databases | PRIDE; PXD006561 |
| Entry history | |
| Entry creation | 23-Jun-2022 |
| Last entry update | 10-Apr-2025 |
| Version number | 9 |